Tusholdings
VC Fund
Beijing, China
Tusholdings is a large integrated enterprise that takes full responsibility for developing, constructing, operating and managing TusPark.As the flagship product of Tus-Holdings, TusPark(Beijing) is currently the largest single university science park in the world, with building area of 770,000 square meters, and more than 1500 enterprises havingbeen settled in the park. TusPark has become a gathering place for multi-national corporation R&D headquarters, China technology enterprise headquarters as well as innovation enterprises. It has become an important platform of Tsinghua University to serve the society and promote regional innovation, as well as a famous brand in China and even in the global science park industry. With more than two decades of development, Tus-Holdings has accumulated a wealth of experience in the development and operation of university science parks and established a high-caliber management team, actively promoting the organic interaction between innovative resources and the regional economy and successfully building up a nationwide innovation system with more than 300 incubators, science parks and science cities as the carrier. The radial network of Tus-Holdings covers more than 50 cities and regions including Hong Kong, Macau, the USA, the UK, Italy, Russia, Australia, Switzerland, Holland, Sweden, South Korea, Pakistan, Thailand, Egypt, Brazil, etc., being a new force of China's innovation system. TusHoldings actively responds to the national strategy of innovation-driven development in implementation of Tsinghua University’s role of serving the society. Under the overall objective of “striving to become a Chinese leader and a global model of S&T service industry”, with science park as the carrier, with S&T industry as the support, with S&T finance as a link, with Internet, big data and other new generation information technology as the basis, TusHoldings forms an innovation network with shared knowledge, information, talent, capital and other resources, makes clustering service innovation and promotes innovation, forming a business structure featuring synergetic trinity of “Science Park, S&T industry, and S&T finance”. So far, it has become China's new force in the process of building scientific and technological power, also a technology service provider with rich experience and wisdom, as well as comprehensive business capabilities.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Tusholdings invests in
Stages Tusholdings invests in
Countries Tusholdings invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Angel
- $411k–$425k
- Series A
- $1.4M–$105M
- Series C
- $16M–$142M
Investment Focus
Industry
- Manufacturing 6 (19%)
- Electronics 5 (16%)
- Biotechnology 4 (13%)
- Robotics 3 (9%)
- Information Technology 3 (9%)
Stage
- Angel 9 (28%)
- Series A 9 (28%)
- Series C 5 (16%)
- Seed 2 (6%)
- Series B 2 (6%)
Country
- China 25 (78%)
- France 2 (6%)
- United States 1 (3%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
CAI Xiaowei
President & CFO
|
President & CFO | Total investments: 0 | Find email | |
WANG Shugui
COO
|
COO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Embodied AI
|
Embodied AI s a general terminal service robot provider focusing on the commercial cleaning field, committed to applying advanced artificial intelligence technology to the research and development and manufacturing of robots. It is focused on creating high-quality intelligent general commercial cleaning robot products in hospitals, supermarkets,offices and other scenarios, leading the intelligent development of the cleaning field. | Venture - Series Unknown / Jun 25, 2025 | |
Stilla Technologies
|
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System.Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all LifeSciences areas: research, therapeutics, and all the “omics”. | $26.5M / Series C / Feb 22, 2024 | |
|
Qingke Dynamics
|
Qingke Dynamics is a microgas turbine equipment manufacturer that focuses on emerging clean energy technology, steam turbines, auxiliary equipment sales, research and development | Angel / Sep 01, 2023 | |
Entropy Technology
|
Entropy Technology is a semiconductor heating material research and development enterprise. | Seed / Aug 02, 2022 | |
Allystar Technology
|
Allystar Technology (Shenzhen) Co. Ltd. is a spin-out from the GNSS chipsets designing department established in May 2013, subsidiary to China Electronics Corporation (CEC) - the World’s Top 500 enterprises. On December 6th 2016, the GNSS chipsets designing department was officially independent to match up with CEC planning to relocate to south.Allystar is a joint-venture invested by: CEC, BAIC Group, SAIC Motor, Ningbo Bird (Stock Code: 600130), and Jinjia Group (Stock Code: 002191). The capital is 400 Million RMB. It is a sample joint-ventured enterprise reformed of Central Enterprises, Local State-owned Enterprises and Social investors. Allystar is officially located in Shenzhen as the key enterprises introduced by the People's Government of Shenzhen Municipality of the Weak Link in 2016. | $15.8M / Series C / Mar 07, 2022 | |
|
Stilla Technologies
|
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System.Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all LifeSciences areas: research, therapeutics, and all the “omics”. | $34.9M / Debt Financing / Nov 23, 2021 | |
Hefei Itron Microelectronics Technology
|
Hefei Itron Microelectronics Technology Co., Ltd. was established in June 2015 and is headquartered in Hefei. It is a Chinese integrated circuit design enterprise, national high-tech enterprise, national software enterprise, and national AAA-level credit that specializes in high-performance analog and digital-analog mixing. Enterprises, the firstbatch of listed enterprises on the Anhui Science and Technology Innovation Board, and high-growth enterprises in Hefei. | Series A / Nov 02, 2021 | |
Slichem
|
Slichem engages in the development of liquid crystal materials and fine chemicals. Its main products include liquid crystal materials for display and OLED materials. There are more than 800 series of mixed liquid crystal products and more than 2000 varieties of single liquid crystal products. | $105.1M / Series A / May 21, 2021 | |
CapitalBio Technology
|
CapitalBio Technology is an industry-leading life science company that develops and commercializes total health-care solutions. Their company provides a comprehensive portfolio of top-quality products to a diverse customer base ranging from biomedical researchers to healthcare professionals. Their products include an innovative and broad spectrumof microarray and microfluidic chips and related instruments, software and databases, reagents and consumables for basic and translational research, drug development, clinical diagnostics, biosafety and food safety, and molecular breeding.As a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, CapitalBio Technology was registered in August 2012 and is headquartered in Economic-Technological Development Area in Beijing. CapitalBio Technology is a leading life science company that develops and commercializes total health-care solutions. With more than 35,000 square meters of office space, CapitalBio Technology employs more than 500 employees; 86 percent of these employees have at least Bachelor-level degrees, 14 of which are doctors or post-doctorates. | $113M / Series C / Jun 29, 2020 | |
Robocath
|
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions.R-One™is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs.Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all. | $43.5M / Series C / Apr 29, 2020 | |
| See all 32 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tusholdings invest in?
Tusholdings invests primarily in Manufacturing, Electronics and Biotechnology startups, most often at Angel and Series A stage. Most of the 32 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Tusholdings's check size?
Tusholdings typically joins rounds of $411k–$425k at Angel, $1.4M–$105M at Series A and $16M–$142M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tusholdings participates in.
How do I contact Tusholdings?
Public channels for Tusholdings include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tusholdings?
The team at Tusholdings includes CAI Xiaowei (President & CFO) and WANG Shugui (COO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
